214MO Sacituzumab govitecan (SG) efficacy in hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+/HER2–) metastatic breast cancer (MBC) by HER2 immunohistochemistry (IHC) status in the phase III TROPiCS-02 study

P. Schmid, J. Cortés, F. Marmé, H. S. Rugo, Sara M. Tolaney, Mafalda Oliveira, Delphine Loirat, Komal Jhaveri, Oh Kyu Yoon, Monica Motwani, H. Wang, Rosemary Delaney, Amit Bardia